What Is MuGard™?
This information is intended for US Healthcare Professionals and Patients
MuGard™ is a mucoadhesive oral wound rinse available by prescription only.
When swirled gently around the mouth, the mucoadhesive formulation results in the formation of a protective coating over the oral mucosa. MuGard is supplied in plastic bottles and is designed for the management of oral wounds such as mucositis, stomatitis, aphthous ulcers and traumatic ulcers.
MuGard™ Mucoadhesive Oral Wound Rinse is indicated for the management of oral mucositis/stomatitis (that may be caused by radiotherapy and/or chemotherapy) and all types of oral wounds (mouth sores and injuries), including aphthous ulcers/canker sores and traumatic ulcers, such as those caused by oral surgery or ill-fitting dentures or braces.
Contraindications: MuGard is contraindicated in patients with known hypersensitivity to any of the ingredients in the formulation.
Special Precautions for Use: Avoid eating or drinking for at least one hour after rinsing with MuGard. After use, replace the bottle cap and tightly seal the bottle. Do not use this product after the expiration date shown on the carton and product label. Dilution of the product prior to use is not recommended.
To access the full prescribing information, please click here.
In June 2013, AMAG Pharmaceuticals, Inc. acquired the U.S. rights to promote MuGard™ Mucoadhesive Oral Wound Rinse. Click here to see the press release.
The MuGard Patient Reimbursement and Support Center will work on the patient's behalf to deliver MuGard directly to your patient's door.
If you have questions about MuGard, or wish to contact someone regarding MuGard, please e-mail AMAG at: firstname.lastname@example.org.
If you are a U.S. health care professional already working with a MuGard sales representative, you may continue to contact that person as usual.
MuGard is a trademark of Access Pharmaceuticals, Inc.